[1] |
YANG Xin, ZHANG Jing, LI Zixiao, WANG Yongjun.
Construction and Development of Quality Control Indicator System for Single Disease
[J]. Chinese Journal of Stroke, 2024, 19(1): 22-27.
|
[2] |
YANG Xin, LI Zixiao, WANG Yongjun.
Revision Process of Medical Quality Control Indicators in Cerebral Infarction
[J]. Chinese Journal of Stroke, 2024, 19(1): 29-34.
|
[3] |
The Cerebrovascular Disease Working Group of National Center for Healthcare Quality Management in Neurological Diseases.
Medical Quality Control Indicators for Cerebral Infarction (2020 Edition)
[J]. Chinese Journal of Stroke, 2024, 19(1): 35-43.
|
[4] |
WANG Jing, LI Zixiao, DONG Qiang, ZHAO Xingquan.
Interpretation of Medical Quality Control Indicators for Intracerebral Hemorrhage
[J]. Chinese Journal of Stroke, 2024, 19(1): 50-54.
|
[5] |
LU Lu, XIONG Weixi, ZHOU Dong.
The Construction of the Medical Quality Control System for Epilepsy and Convulsive Status Epilepticus
[J]. Chinese Journal of Stroke, 2024, 19(1): 55-57.
|
[6] |
The Epilepsy Working Group of National Center for Healthcare Quality Management in Neurological Diseases.
Medical Quality Control Indicators for Epilepsy and Convulsive Status Epilepticus
[J]. Chinese Journal of Stroke, 2024, 19(1): 58-65.
|
[7] |
HE Ji, FAN Dongsheng.
Establish a Medical Standard and Continuous Quality Improvement System for Motor Neuron Disease in China
[J]. Chinese Journal of Stroke, 2024, 19(1): 66-68.
|
[8] |
The Motor Neuron Disease Working Group of National Center for Healthcare Quality Management in Neurological Diseases.
Medical Quality Control Indicators for Amyotrophic Lateral Sclerosis
[J]. Chinese Journal of Stroke, 2024, 19(1): 69-75.
|
[9] |
YANG Jiaxin, HE Chunyu, LIU Lei, CHEN Wenbo, XIE Yan.
Prediction Models of Symptomatic Intracerebral Hemorrhage after Intravenous Thrombolysis in Acute Ischemic Stroke: A Systematic Review
[J]. Chinese Journal of Stroke, 2024, 19(1): 76-86.
|
[10] |
ZHANG Qian, JI Ruijun, ZHAO Meng, WANG Wenjuan, LU Jingjing, LI Na, LIU Yanfang, BIAN Liheng, YU Songlin, LI Hao, ZHANG Qian, WU Jianwei, WANG Dandan, WANG Jing, LI Zhaoxia, JIANG Ruixuan, KANG Kaijiang, XUE Yimeng, YA Xiaolong, HE Qiheng, MO Shaohua, ZHAO Xingquan, ZHAO Jizong, the Writing Committee of Chinese Stroke Association Guidelines for Clinical Management of Cerebrovascular Diseases ( Contributed equally).
Chinese Stroke Association Guidelines for Clinical Management of Cerebrovascular Diseases (Second Edition) (Excerpt) ——Chapter Five Clinical Management of Intracerebral Hemorrhage
[J]. Chinese Journal of Stroke, 2023, 18(9): 1014-1023.
|
[11] |
FANG Xiaomeng, YUAN Qiaoling, WANG Shuo.
Factors Related to the Deep Vein Thrombosis in Severe Spontaneous Intracerebral Hemorrhage Patients after Surgical Treatment
[J]. Chinese Journal of Stroke, 2023, 18(8): 891-897.
|
[12] |
LI Guangshuo, ZHAO Xingquan.
Interpretation of the Keypoints and Updates on National Clinical Guideline for Stroke for the United Kingdom and Ireland (Edition 2023) —Hemorrhagic Stroke
[J]. Chinese Journal of Stroke, 2023, 18(12): 1365-1369.
|
[13] |
WU Na, WANG Liyuan, LI Guangshuo, XIONG Yunyun.
Interpretation of the Keypoints and Updates on National Clinical Guideline for Stroke for the United Kingdom and Ireland (Edition 2023) —Long-Term Management and Secondary Prevention
[J]. Chinese Journal of Stroke, 2023, 18(12): 1383-1390.
|
[14] |
The Neurocritical Care Working Group of National Center for Healthcare Quality Management in Neurological Diseases.
Quality Control Indicators in Neurocritical Care
[J]. Chinese Journal of Stroke, 2023, 18(12): 1450-1455.
|
[15] |
ZHANG Linlin, ZHOU Jianxin.
Neurocritical Care Quality Control 2018—2023: From Resource Investigation to Quality Control Indicators
[J]. Chinese Journal of Stroke, 2023, 18(12): 1456-1459.
|